Teva Scores FCA Trial Delay, Kickback Law Appeal At 1st Circ.

By Jeff Overley · August 14, 2023, 11:00 PM EDT

Teva Pharmaceuticals won a major reprieve Monday when a Massachusetts federal judge delayed an impending False Claims Act trial threatening $10 billion in liability and permitted the drugmaker to pursue First...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al

Case Number

1:20-cv-11548

Court

Massachusetts

Nature of Suit

Other Statutes: False Claims Act

Date Filed

August 18, 2020